BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 1 day ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 1 day ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 1 day ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 day ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 1 day ago Abbott reports positive results from study on its atrial fibrillation therapies 1 day ago Atmus Welcomes Heath Sharp to Board of Directors 1 day ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 1 day ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 1 day ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 1 day ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 1 day ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 day ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 1 day ago Abbott reports positive results from study on its atrial fibrillation therapies 1 day ago Atmus Welcomes Heath Sharp to Board of Directors 1 day ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 1 day ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT

LLY Earnings: All you need to know about Eli Lilly Q2 2020 earnings results

Eli Lilly and Company (NYSE: LLY) reported second quarter 2020 earnings results today. Revenues declined 2% year-over-year to $5.4 billion. Reported net income rose 6% to $1.4 billion and EPS grew 8% to $1.55. Adjusted EPS increased 26% to $1.89.   For fiscal year 2020, the company expects reported EPS to be $6.48-6.68 and adjusted […]

July 30, 2020 1 min read

Eli Lilly and Company (NYSE: LLY) reported second quarter 2020 earnings results today.

Revenues declined 2% year-over-year to $5.4 billion.

Reported net income rose 6% to $1.4 billion and EPS grew 8% to $1.55. Adjusted EPS increased 26% to $1.89.  

For fiscal year 2020, the company expects reported EPS to be $6.48-6.68 and adjusted EPS to be $7.20-7.40. Revenue is expected to come between $23.7 billion and $24.2 billion.

Past Performance

ADVERTISEMENT